Company: PFSA
Filing Date: 2025-05-13
Form Type: S-4/A
Source: 0001213900-25-042224
Chunk: 206

Company: Profusa, Inc.
Filing Date: 2025-05-13
Form: S-4/A
Chunk 206
---
 personnel; •investors’ general perception of New Profusa’s business or management; •trading volume of New Profusa Common Stock; •overall performance of the equity markets; •publication of research reports about New Profusa or its industry or positive or negative recommendations or withdrawal of research coverage by securities analysts; •the impacts of the ongoing COVID -19pandemic and related restrictions; •general political and economic conditions; and •other events or factors, many of which are beyond Profusa’s control. In addition, in the past, stockholders have initiated class action lawsuits against public companies following periods of volatility in the market prices of these companies’ stock. Such litigation, if instituted against New Profusa, could cause it to incur substantial costs and divert management’s attention and resources from its business. 93 Upon the completion of the Business Combination, the Profusa shareholders will be able to control or exert substantial influence over all matters submitted to our stockholders for approval, including the election of directors and amendments of our organizational documents, and an approval right over any acquisition or liquidation of New Profusa. Upon the completion of the Business Combination, the Profusa shareholders will hold between approximately 47.0% (if no public shares are redeemed) and 47.1% (if the maximum number of public shares are redeemed). Accordingly, upon the completion of the Business Combination, the Profusa shareholders will be able to control or exert substantial influence over all matters submitted to our stockholders for approval, including the election of directors and amendments of our organizational documents, and an approval right over any acquisition or liquidation of New Profusa. The Profusa shareholders may have interests that differ from those of the other stockholders and may vote in a way with which the other stockholders disagree and which may be adverse to their interests. This concentrated control may have the effect of delaying, preventing or deterring a change in control of New Profusa, could deprive New Profusa’s stockholders of an opportunity to receive a premium for their capital stock as part of a sale of New Profusa, and might ultimately affect the market price of shares of New Profusa Common Stock. New Profusa’s continued eligibility for listing on Nasdaq will depend on New Profusa’s compliance with the Nasdaq’s continued listing standards and may depend on the number of our shares that are redeemed. In connection with the completion of the Business Combination, we intend to list New Profusa Common Stock and warrants on the Nasdaq under the symbols “PFSA” and “PFSA